HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norman Relkin Selected Research

Biomarkers (Surrogate Marker)

5/2017Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
1/2016Structural connectome disruption at baseline predicts 6-months post-stroke outcome.
6/2015Exploring the brain's structural connectome: A quantitative stroke lesion-dysfunction mapping study.
1/2015Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease.
1/2008Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy.
2/2007Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.
10/2006Proteomic analysis of cerebrospinal fluid changes related to postmortem interval.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norman Relkin Research Topics

Disease

13Alzheimer Disease (Alzheimer's Disease)
05/2017 - 07/2002
3Normal Pressure Hydrocephalus
05/2017 - 04/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
05/2017 - 01/2014
2Stroke (Strokes)
01/2016 - 10/2006
2Dementia (Dementias)
01/2008 - 09/2004
2Amyloid Plaque
07/2002 - 07/2002
1Overactive Urinary Bladder (Overactive Bladder)
05/2019
1Ischemic Stroke
06/2015
1Atrophy
01/2015
1Cognitive Dysfunction
07/2014
1Neuroinflammatory Diseases
01/2014
1Neuroblastoma
06/2008
1Human Influenza (Influenza)
07/2002

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
05/2017 - 10/2006
4Intravenous Immunoglobulins (IVIG)FDA Link
07/2014 - 06/2008
4AntibodiesIBA
01/2014 - 07/2002
4Proteins (Proteins, Gene)FDA Link
02/2007 - 07/2002
3Amyloid beta-PeptidesIBA
05/2017 - 10/2010
3Amyloid (Amyloid Fibrils)IBA
07/2014 - 07/2002
2Acetazolamide (Diamox)FDA LinkGeneric
04/2015 - 04/2014
2Immunoglobulin G (IgG)IBA
07/2014 - 10/2010
2Apolipoproteins E (ApoE)IBA
07/2004 - 07/2002
2Peptides (Polypeptides)IBA
07/2002 - 07/2002
1Glucose (Dextrose)FDA LinkGeneric
07/2014
1tau Proteins (tau Protein)IBA
01/2014
1Donepezil (Aricept)FDA LinkGeneric
01/2008
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2006
1PesticidesIBA
09/2004
1Matrix Metalloproteinases (MMPs)IBA
08/2003
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2003
1AntigensIBA
07/2002
1Protein Isoforms (Isoforms)IBA
07/2002
1Hemagglutinins (Hemagglutinin)IBA
07/2002
1Influenza Vaccines (Influenza Vaccine)FDA Link
07/2002
1ApolipoproteinsIBA
07/2002

Therapy/Procedure

2Therapeutics
07/2014 - 01/2008
1Activities of Daily Living (ADL)
05/2019
1Immunomodulation
01/2014